📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome (2012)

First Author: Spiller R

Attributed to: Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome(IBS-D) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5056/jnm.2012.18.3.258

PubMed Identifier: 22837873

Publication URI: http://europepmc.org/abstract/MED/22837873

Type: Journal Article/Review

Parent Publication: Journal of Neurogastroenterology and Motility

Issue: 3

ISSN: 2093-0879